Trexquant Investment LP Monte Rosa Therapeutics, Inc. Transaction History

Trexquant Investment LP

  • $7.59 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
BUY
$4.78 - $7.22 $52,269 - $78,950
10,935 Added 74.28%
25,657 $122,000
Q2 2023

Aug 11, 2023
SELL
$4.53 - $8.4 $31,723 - $58,825
-7,003 Reduced 32.23%
14,722 $100,000
Q1 2023

May 15, 2023
BUY
$5.95 - $8.21 $28,506 - $39,334
4,791 Added 28.29%
21,725 $169,000
Q4 2022

Feb 13, 2023
SELL
$6.71 - $9.72 $165,508 - $239,753
-24,666 Reduced 59.29%
16,934 $128,000
Q3 2022

Nov 14, 2022
BUY
$7.17 - $12.16 $298,272 - $505,856
41,600 New
41,600 $340,000

Others Institutions Holding GLUE

# of Institutions
83
Shares Held
43.9M
Call Options Held
141K
Put Options Held
31.2K
View Full List

About Monte Rosa Therapeutics, Inc.

GLUE Quotes by TradingView
  • Ticker GLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,713,900
  • Market Cap $329M
  • Description
  • Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...
More about GLUE
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email